Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herskovitz, S.
Right arrow Articles by Lantos, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herskovitz, S.
Right arrow Articles by Lantos, G.
NEUROLOGY 1988;38:1714
© 1988 American Academy of Neurology

Neuro-Behcet's disease

CT and clinical correlates

Steven Herskovitz, MD, Richard B. Lipton, MD and George Lantos, MD

Departments of Neurology (Drs. Herskovitz and Lipton) and Neuroradiology (Dr. Lantos), Albert Einstein College of Medicine, Bronx, NY.

We examined the serial CTs and clinical courses of five patients with neuro-Behcet's disease and reviewed ten previously reported cases, all with focal CT abnormalities. The CT lesions were in the brainstem (8 patients), basal ganglia (7), thalamus (4), or hemispheric white matter (7). Of the 13 patients who received contrast, nine had lesions that showed enhancement. In five, lesions were visualized with contrast that were not apparent without it. The CT lesions were usually accompanied by corresponding clinical deficits, although in some patients deficits were more extensive than the CT predicted. In nine patients, contrast enhancement decreased or disappeared over days to weeks, often with associated clinical improvement. In eight patients followed serially, CT abnormalities resolved completely or substantially. Based on these cases, we conclude that (1) CT abnormalities of gray and white matter occur commonly in neuro-Behcet's disease with focal deficits, and help support the diagnosis; (2) CT abnormalities, particularly contrast enhancement, correlate well with the activity of parenchymal disease; and (3) the concomitant improvement of clinical and CT abnormalities with resolution of contrast enhancement suggests that partially reversible inflammatory changes associated with breakdown of the blood-brain barrier may produce some of the neurologic and radiographic deficits in this illness.

Address correspondence and reprint requests to Dr. Herskovitz, Department of Neurology, Montefiore Medical Center, 111 E. 210 Street, Bronx, NY 10467.

Presented in part at the thirty-eighth annual meeting of the American Academy of Neurology, New Orleans, LA, April, 1986.

Received December 4, 1987. Accepted for publication in final form April 26, 1988.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
N. Koçer, C. Islak, A. Siva, S. Saip, C. Akman, O. Kantarci, and V. Hamuryudan
CNS Involvement in Neuro-Behcet Syndrome: An MR Study
AJNR Am. J. Neuroradiol., June 1, 1999; 20(6): 1015 - 1024.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.